Li‐Jian Liang
Papers
2
Total Citations
19
H-Index
2
About
Dr. Li‐Jian Liang is a pioneering hepatobiliary and pancreatic surgeon whose research focuses on advancing minimally invasive surgical techniques for complex gastrointestinal malignancies. His major contributions center on evaluating the safety, efficacy, and short-term outcomes of robotic-assisted radical resections for challenging conditions, particularly perihilar cholangiocarcinoma (pCCA) and pancreatoduodenectomy. In his landmark 2022 study, Dr. Liang demonstrated that robotic-assisted radical resection for pCCA is both feasible and safe, achieving comparable outcomes to traditional open surgery while offering the benefits of minimally invasive approaches—work that has garnered 17 citations and helped define a new frontier in surgical oncology. His 2025 investigation into robotic-assisted versus open pancreatoduodenectomy, employing rigorous inverse probability of treatment weighting analysis, further solidifies his role in evidence-based surgical innovation, providing critical data on short-term recovery and complication rates. With a growing citation impact, Dr. Liang’s research is instrumental in guiding clinical decision-making and expanding the application of robotics in high-risk hepatobiliary surgery, making him a key figure in the evolution of precision surgical care.
Research Focus
Key Achievements
Top Papers
- 1
- 2